Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens
- PMID: 11337315
- DOI: 10.1016/s0090-4295(00)01052-9
Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens
Abstract
Objectives: To determine the effects of a saw palmetto herbal blend (SPHB) compared with finasteride on prostatic tissue androgen levels and to evaluate needle biopsies as a source of tissue for such determinations.
Methods: Prostate levels of testosterone and dihydrotestosterone (DHT) were measured on 5 to 10-mg biopsy specimens (18-gauge needle cores) in three groups of men with symptomatic benign prostatic hyperplasia: 15 men receiving chronic finasteride therapy versus 7 untreated controls; 4 men undergoing prostate adenomectomy to determine sampling variability (10 specimens each); and 40 men participating in a 6-month randomized trial of SPHB versus placebo, before and after treatment.
Results: Prostatic tissue DHT levels were found to be several times higher than the levels of testosterone (5.01 versus 1.51 ng/g), that ratio becoming reversed (1.05 versus 3.63 ng/g) with chronic finasteride therapy. The finasteride effect was statistically significant for both androgens (P <0.01), and little overlap of individual values between finasteride-treated and control patients was seen. In the randomized trial, tissue DHT levels were reduced by 32% from 6.49 to 4.40 ng/g in the SPHB group (P <0.005), with no significant change in the placebo group.
Conclusions: For control versus finasteride-treated men, the tissue androgen values obtained with needle biopsy specimens were similar-both for absolute values and the percentage of change-to those previously reported using surgically excised volumes of prostatic tissue. The quantification of prostatic androgens by assay of needle biopsies is thus feasible and offers the possibility of serial studies in individual patients. The SPHB-induced suppression of prostatic DHT levels, modest but significant in a randomized trial, lends an element of support to the hypothesis that inhibition of the enzyme 5-alpha reductase is a mechanism of action of this substance.
Similar articles
-
Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism.Urology. 2002 Oct;60(4):617-22. doi: 10.1016/s0090-4295(02)01838-1. Urology. 2002. PMID: 12385921 Clinical Trial.
-
Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.Clin Endocrinol (Oxf). 1997 Feb;46(2):137-44. doi: 10.1046/j.1365-2265.1997.950908.x. Clin Endocrinol (Oxf). 1997. PMID: 9135694 Clinical Trial.
-
Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.Prostate. 1998 Oct 1;37(2):77-83. doi: 10.1002/(sici)1097-0045(19981001)37:2<77::aid-pros3>3.0.co;2-i. Prostate. 1998. PMID: 9759701
-
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.Eur Urol. 2000 Apr;37(4):367-80. doi: 10.1159/000020181. Eur Urol. 2000. PMID: 10765065 Review.
-
[Hormonal therapy for benign prostatic hyperplasia].Nihon Rinsho. 2002 Dec;60 Suppl 11:358-61. Nihon Rinsho. 2002. PMID: 12599600 Review. Japanese. No abstract available.
Cited by
-
Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome.Curr Urol Rep. 2005 Jul;6(4):290-5. doi: 10.1007/s11934-005-0026-1. Curr Urol Rep. 2005. PMID: 15978232 Review.
-
Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases.Curr Med Chem. 2016;23(8):792-815. doi: 10.2174/0929867323666160210125642. Curr Med Chem. 2016. PMID: 26861003 Free PMC article. Review.
-
Current Understanding of Androgen Signaling in Prostatitis and its Treatment: A Review.Curr Med Chem. 2024;31(27):4249-4266. doi: 10.2174/0109298673279207231228070533. Curr Med Chem. 2024. PMID: 38243983 Review.
-
Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines.Evid Based Complement Alternat Med. 2006 Mar;3(1):117-24. doi: 10.1093/ecam/nel001. Evid Based Complement Alternat Med. 2006. PMID: 16550232 Free PMC article.
-
Use of 5alpha-reductase inhibitors to prevent benign prostatic hyperplasia disease.Curr Urol Rep. 2006 Jul;7(4):293-303. doi: 10.1007/s11934-996-0009-x. Curr Urol Rep. 2006. PMID: 16930501 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical